کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
10969519 | 1102965 | 2010 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Human αIFN co-formulated with milk derived E2-CSFV protein induce early full protection in vaccinated pigs
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
LD50DMEMPK-15Dulbecco's modified Eagle mediaNPLACSFVPKRinterferon - اینترفرونhuman interferon - اینترفرون انسانIFN - اینترفرون هاClassical swine fever - تب کلاسیکlethal dose 50% - دوز مرگبار 50٪CSF - مایع مغزی نخاعیOAS - واحهSubunit vaccine - واکسن SubunitLive attenuated vaccines - واکسن های واکسن زندهClassical swine fever virus - ویروس کبد خوکDouble-stranded RNA-dependent protein kinase - پروتئین کیناز وابسته به RNA دوجانبهLAV - کم
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
ایمونولوژی
پیش نمایش صفحه اول مقاله

چکیده انگلیسی
Subunit vaccines are a suitable alternative for the control of classical swine fever. However, such vaccines have as the main drawback the relatively long period of time required to induce a protective response, which hampers their use under outbreak conditions. In this work, type I interferon is used as an immunostimulating molecule in order to increase the immunogenicity of a vaccine candidate based on the E2-CSFV antigen produced in goat milk. Pigs vaccinated with E2-CSFV antigen co-formulated with recombinant human alpha interferon were protected against clinical signs and viremia as early as 7 days post-vaccination. It was also demonstrated that interferon stimulates a response of specific anti-CSFV neutralizing antibodies. The present work constitutes the first report of a subunit vaccine able to confer complete protection by the end of the first week after vaccination. These results suggest that the E2-CSFV antigen combined with type I interferons could be potentially used under outbreak conditions to stop CSFV spread and for eradication programs in CSF enzootic areas.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 28, Issue 50, 23 November 2010, Pages 7907-7914
Journal: Vaccine - Volume 28, Issue 50, 23 November 2010, Pages 7907-7914
نویسندگان
Jorge R. Toledo, Maritza Barrera, Omar Farnós, Silvia Gómez, MarÃa P. RodrÃguez, Felix Aguero, Valeska Ormazabal, Natalie C. Parra, Lester Suárez, Oliberto Sánchez,